Anti-Müllerian hormone: clinical insights into a promising biomarker of ovarian follicular status
Authors:
- Daniel H Méndez LozanoDLDaniel H Méndez Lozano
- Joëlle TaiebJTJoëlle Taieb
- Laetitia HestersLHLaetitia Hesters
- René FrydmanRFRené Frydman
- Renato FanchinRFRenato Fanchin
- 1 January 2006
- journal article
- review article
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 12 (6) , 695-703
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular statusFertility and Sterility, 2005
- Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transitionMenopause, 2004
- Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiolFertility and Sterility, 2004
- Serum müllerian-inhibiting substance levels during normal menstrual cyclesFertility and Sterility, 2000
- Detection of Minimal Levels of Serum Anti-Mullerian Hormone during Follow-Up of Patients with Ovarian Granulosa Cell Tumor by Means of a Highly Sensitive Enzyme-Linked Immunosorbent AssayThe Journal of Clinical Endocrinology & Metabolism, 2000
- Tissue harmonic imaging: Why does it work?Journal of the American Society of Echocardiography, 1998
- Elevated basal estradiol levels have no negative prognosis in young women undergoing ART cyclesGynecological Endocrinology, 1998
- Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older womenThe Journal of Clinical Endocrinology & Metabolism, 1996
- Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid mullerian-inhibiting substance and androgen contentThe Journal of Clinical Endocrinology & Metabolism, 1993
- Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cellsCell, 1986